Tiziana Life Sciences gets FDA approval to kick-off Phase I clinical trial with orally administered foralumab in healthy volunteers
September 16, 2019 Off

Tiziana Life Sciences gets FDA approval to kick-off Phase I clinical trial with orally administered foralumab in healthy volunteers

By BusinessWire

Tiziana Life Sciences got from the U.S. Food and Drug Administration (FDA) signal to start a Phase I clinical trial in healthy volunteers using a novel oral enteric-coated capsule formulation of Foralumab, a fully human monoclonal antibody (mAb), in collaboration with the Brigham and Women’s Hospital (BWH), Harvard Medical School, Boston, MA.

Accenture and Bayer streamline drug development processes through Intient clinical platform
September 16, 2019 Off

Accenture and Bayer streamline drug development processes through Intient clinical platform

By BusinessWire

Accenture (NYSE: ACN) has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve patient outcomes.